10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
Rhea-AI Summary
10x Genomics (Nasdaq: TXG) said management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:50 a.m. ET. A live webcast will be available via the company's Investors website and archived for at least 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – TXG
In the Feb 20 session, TXG declined 1.62%, reflecting a mild negative market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Earnings results | Negative | -8.6% | Q4 and full-year 2025 results with modest growth and narrowed losses. |
| Feb 04 | AI partnership | Positive | -1.1% | Partnership with PharosAI to build a large multimodal cancer dataset. |
| Jan 22 | Earnings date set | Neutral | -3.5% | Announcement of date and webcast details for Q4 and FY 2025 results. |
| Jan 15 | Reverse stock split | Neutral | +1.3% | Amcor completed a 1-for-5 reverse stock split, a peer-sector event. |
| Jan 12 | Clinical study launch | Positive | -3.2% | Launch of 1,000-patient autoimmune disease study with Brigham & Women’s. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows TXG often trading lower following earnings, partnerships, and research collaborations, suggesting a pattern of negative or cautious price reactions even to ostensibly constructive news.
Over the last few months, TXG has reported Q4 and full-year 2025 results, issued an outlook for 2026, and detailed these metrics further in a 10-K and 8-K. It also announced an AI-focused cancer research partnership and a large autoimmune disease study targeting 1,000 patients. Despite these strategic initiatives, shares declined after several of these updates, framing today’s routine conference participation within a backdrop of cautious market responses.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-participate-in-the-46th-annual-td-cowen-health-care-conference-302692977.html
SOURCE 10x Genomics, Inc.